A New Revolutionary Technology That Can Predict Cardiovascular Risk With Precision, Part 2

Podcast

Dr. Hoffman continues his conversation with Dr. James Min, an expert on cardiovascular imaging and founder and CEO of Cleerly, a company that has developed an improved scan that can differentiate between dangerous unstable plaque, and more benign lesions. Click HERE for part 1.

Share:
Subscribe to the Intelligent Medicine Podcast for Free from your Favorite Podcast Provider










Facebook Twitter YouTube RSS Google Podcasts Apple Podcasts Spotify

TWITTER